Silod, Kienzces Paul E.
HRN: 17-25-56 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2022
CEFUROXIME 1.5GM (VIAL)
09/24/2022
09/30/2022
IV
1.5gm
Q8
T/C Acute Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes